Market Overview - The global dental market was valued at US$ 37.91 billion in 2024 and is projected to reach US$ 67.86 billion by 2033, with a CAGR of 7.55% from 2025 to 2033 [1]. Demand Drivers - The increasing prevalence of dental disorders is significantly influencing demand, with 36 million Americans currently living without any natural teeth, highlighting the urgent need for effective implant and denture solutions [2]. - An additional 120 million people in the U.S. are missing at least one tooth, driving demand for crowns, bridges, and implant restorations [3]. Technological Advancements - CAD/CAM milling technology is transforming dental restoration fabrication, allowing for exceptional precision and consistency in producing crowns, bridges, and veneers [4]. - Over 90,000 dental clinics worldwide have integrated chairside milling stations, enhancing efficiency and patient convenience by allowing restorations to be fabricated and fitted within the same appointment [5]. - Approximately 600,000 dentists globally have completed CAD/CAM training, ensuring high-quality restorations and optimized treatment outcomes [6]. Material Innovations - Adhesives and bonding agents account for a significant 35% share in various clinical procedures, enhancing the strength and stability of dental treatments [7]. - A study indicated that the use of universal bonding agents can increase bond strength from 8 megapascals to nearly 30, improving the durability of restorations [8]. - Adhesives are fundamental in over 60 million composite restoration procedures annually in the U.S., underscoring the critical demand for reliable adhesives [9]. Digital Dentistry - Digital dentistry has captured over 34% of the market share, streamlining clinical workflows and enhancing patient experiences [11]. - Approximately 40,000 digital scanners were operational in U.S. dental practices as of 2021, reflecting the growing confidence in technology-driven diagnostics [12]. - Digital impression systems improve the fit of dental restorations, reducing the need for adjustments and enhancing clinical efficiency [13]. Regional Insights - North America commands over 40% of the global dental market share, driven by the U.S. and Canada, with significant investments in modernizing dental practices [14]. - The U.S. has over 200,000 practicing dentists, ensuring access to essential oral health interventions [15]. - Dental disorders result in over 164 million work hours lost annually in the U.S., highlighting the economic impact of untreated conditions [16]. Key Players - Prominent players in the dental market include 3M Company, Ivoclar Vivadent, GC Corporation, and Dentsply Sirona, among others [19].

Core Insights - Dentsply Sirona has appointed Donald Zurbay to its Board of Directors, effective January 10, 2026, to enhance its governance and support its Return-to-Growth Action Plan [1][3][4] Group 1: Appointment of Donald Zurbay - Mr. Zurbay brings over 30 years of experience in finance and accounting, with significant leadership roles in the dental and healthcare industries, including his recent position as President and CEO of Patterson Companies [2][7] - His familiarity with Dentsply Sirona stems from a longstanding partnership between Patterson and the Company, which will aid in strategic decision-making [2][3] - The Board's Corporate Governance and Nominating Committee led Mr. Zurbay's appointment, increasing the Board size from 10 to 11 members [3] Group 2: Growth and Value Creation Committee - A new four-member Growth and Value Creation Committee has been established, co-chaired by the Board Chairman and the Company's President & CEO, to oversee the Return-to-Growth action plan [5][6] - The Board is committed to actively engaging with management to monitor progress, evaluate growth opportunities, and ensure alignment with strategic priorities [6] - This governance structure aims to facilitate timely decision-making and disciplined oversight, enhancing the execution of the growth strategy [6] Group 3: Company Overview - Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, with a history of over a century in the dental industry [8] - The Company offers a comprehensive range of dental and oral health products, as well as consumable medical devices, under a strong portfolio of world-class brands [8] - Dentsply Sirona is headquartered in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY [8]

Core Viewpoint - Envista is positioned as a leader in the dental industry with a focus on growth, operations, and people as part of its new value creation plan [4]. Group 1: Company Overview - Envista has been a leader in the dental industry for over 100 years, indicating its long-standing presence and expertise [3]. - The company is part of the med tech sector, which is characterized by several structurally attractive growth drivers [3]. Group 2: Value Creation Plan - In Q1 of the previous year, Envista introduced a new value creation plan that emphasizes three priority areas: growth, operations, and people [4]. - The presentation will provide an update on the progress of this value creation plan [4].

We partner with dental professionals to improve patients' lives JPM Healthcare Conference 01/01/2025 January 12, 2026 JPM Conference 2026 Forward looking statements/Non-GAAP financial measures FORWARD-LOOKING STATEMENTS Certain statements in this presentation are "forward-looking statements" within the meaning of the U.S. federal securities laws, including statements regarding future financial performance, and the objectives and expectations of management. Terminology such as "believe," "anticipate," "shoul ...

NORTHWOOD, N.H., Jan. 11, 2026 (GLOBE NEWSWIRE) -- What are the key differences between implant dentures and conventional dentures, and how do you know which one is right for you? A new HelloNation article explores this important question with insights from dental expert Anthony Pasquale of Northwood Family Dental Center in Northwood, NH. The article offers a clear explanation of the pros and cons of each option, helping patients understand what to expect from removable dentures compared to implant-supporte ...

ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. With a heritage of category-defining innovation, our brands have shaped modern dentistry: Nobel Biocare introduced the first dental implant, Ormco is a pioneer in both traditional and digital orthodontics, DEXIS has long been at the forefront of 2D, 3D and i ...

A live audio webcast of the event will be available in the Investors section of the Envista website at https://investors.envistaco.com/. Additionally, a replay of the webcast will be available on the Envista website for 30 days following the presentation. ABOUT ENVISTA HOLDINGS CORPORATION Envista is a global leader in the dental industry, uniting more than 30 trusted brands—including DEXIS, Kerr, Nobel Biocare, and Ormco—under one mission: partnering with dental professionals to improve patients' lives. Wi ...

PresentationWe will get started. I'm Elizabeth Anderson. I'm Evercore's health care services and dental analyst. Very pleased to be joined by Eric Hammes and Jim Gustafson from Envista this morning, CFO and VP IR, respectively. As we sort of sit here in December of 2025, we've gotten different signals from different dental participants. And maybe that's a true -- maybe doesn't even -- that's not even true of December 2025, it's been true this whole year. So how do we think about the overall dental market an ...

Core Insights - The conference marks Piper's 37th Annual Healthcare Conference, emphasizing the importance of client relationships and partnerships [1] Group 1: Consumer Confidence - Recent consumer confidence numbers indicate a decline, suggesting potential pressure on the U.S. consumer [3] - There is an expectation of a data vacuum from the government, which may impact the understanding of the current consumer landscape [3] - The macro environment for the U.S. consumer is under scrutiny, with questions about stability and pressure being pertinent for investors [2][3]

Core Insights - Henry Schein, Inc. (HSIC) has expanded its agreement with vVARDIS, gaining exclusive U.S. distribution rights for the drill-free Curodont Repair Fluoride Plus product, effective January 1, 2026, which is expected to enhance the company's Dental business [1][8] - Following the announcement, HSIC shares increased by 0.1%, closing at $73.15 in after-market trading [2] - The company's revenue growth is supported by niche acquisitions and partnerships, with expectations for the latest news to bolster stock performance [3] Company Developments - Curodont is a proprietary solution for treating early-stage cavities without drills or needles, addressing a significant unmet need in dental care [5][6] - The expanded partnership with vVARDIS will enhance Henry Schein's reach across various dental care areas, including general dentistry, orthodontics, and pediatric dentistry [7][8] - Henry Schein is currently the market leader in selling Curodont to general practitioners and Dental Service Organizations (DSOs) in the U.S. and holds exclusive distribution rights in the U.K. [9] Market Outlook - The global dental caries treatment market is projected to grow from $8.01 billion in 2025 to approximately $12.11 billion by 2034, at a CAGR of 4.70% [10] - The rising prevalence of dental diseases necessitates effective treatment options, which supports the growth of the dental caries treatment market [10] Additional Innovations - Henry Schein's dental software business has introduced AI and automation workflows to enhance operational efficiency for dental practices [11] Stock Performance - Year-to-date, HSIC shares have increased by 5.7%, compared to the industry's growth of 15.6% [12]